$TCX Balance Sheet | Understand Stock

$TCX

$10.29 -$0.38 (3.61%) Close

$TCX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net of expected credit losses of 1313000 as of June 30, 2026 and 1259000 as of December 31, 2025
Contract asset, net
Inventory
Derivative instrument asset
Deferred costs of fulfillment, current portion
Income taxes recoverable
Assets held for sale
Prepaid expenses and other
Total current assets
Contract asset, net long-term portion (note 11)
Deferred costs of fulfillment, long-term portion
Derivative instrument asset, long-term portion (note 7)
Investments
Secured notes reserve funds
Deferred tax asset
Property and equipment, net
Right of use lease asset
Contract costs
Intangible assets
Goodwill
Other assets
Total assets

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Accrued liabilities
Customer deposits
Accounts payable and accrued liabilities
Derivative instrument liability
Operating lease liability, current portion
Loan payable, current portion (note 7)
Contract liabilities, current portion
Accreditation fees payable
Income taxes payable
Redeemable preferred units - no par value, 33,333,333 units authorized; 15,243,600 units issued and outstanding as of March 31, 2026 and December 31, 2025
Series A Preferred Units
Total redeemable preferred units - no par value, 33,333,333 units authorized; 15,243,600 units issued and outstanding as of March 31, 2026 and December 31, 2025
Redeemable preferred units - no par value, 33,333,333 units authorized; 15,243,600 units issued and outstanding as of March 31, 2026 and December 31, 2025
Series A Preferred Units
Total redeemable preferred units - no par value, 33,333,333 units authorized; 15,243,600 units issued and outstanding as of March 31, 2026 and December 31, 2025
Other current liabilities
Total current liabilities
Derivative instrument liability, long-term portion (note 7)

Contract liabilities, long-term portion
Accreditation fees payable, long-term portion
Operating lease liability, long-term portion
Syndicated revolver
Notes payable
Other long-term liabilities
Deferred tax liability
Stockholders' deficit
Preferred stock - no par value, 1,250,000 shares authorized; none issued and outstanding
Common stock - no par value, 250,000,000 shares authorized; 11,134,174 and 11,111,453 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' deficit
Total liabilities and stockholders' deficit

Comments